2 results

• Lawsuits Over Testosterone Generic Drugs Survive Pre-emption for Fraudulent Off-Label Marketing

  March 9, 2016

  Austin Kirk

  A federal judge has ruled that plaintiffs can continue to pursue off-label marketing claims against generic testosterone drug manufacturers, even though failure to warn claims are preempted.

• Generic Testosterone Drug Lawsuits Dismissed Based on Federal Preemption

  November 23, 2015

  Austin Kirk

  Heart attack and stroke lawsuits filed against the makers of generic testosterone drugs have been dismissed on preemption grounds, including claims against Depo-Testosterone and Testopel, which some plaintiffs argue are brand name drugs.